A unique antiphospholipid assay recognizing phospholipid mixture compared with criteria antiphospholipid immunoassays in lupus patients

Lupus

Volumn 26, Issue 6, 2017, Pages 606-615

  Zuo, Y ^a   Willis, R ^b   Papalardo, E ^b   Petri, M ^c   Harris, E N ^d   Schleh, A ^b   Deceulaer, K ^d   Smikle, M ^d   Vila L M ^e   Reveille, J D ^f   Alarcon G S ^g   Gonzalez, E B ^b  

^a UNIVERSITY OF TEXAS   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF THE WEST INDIES   (Jamaica)

^e UNIVERSITY OF PUERTO RICO SCHOOL OF MEDICINE   (Puerto Rico)

^f UNIVERSITY OF TEXAS   (United States)

^g UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Anticardiolipin antibodies; antiphospholipid syndrome; classification; pregnancy morbidity; thrombosis

Indexed keywords

BETA2 GLYCOPROTEIN 1 ANTIBODY; CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PHOSPHOLIPID ANTIBODY; BETA2 GLYCOPROTEIN 1;

ADULT; AGED; ANTIPHOSPHOLIPID SYNDROME; ARTERY THROMBOSIS; ARTICLE; AUTOIMMUNITY; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; ECLAMPSIA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORBIDITY; PREDICTIVE VALUE; PREECLAMPSIA; PREGNANCY; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SPONTANEOUS ABORTION; SYSTEMIC LUPUS ERYTHEMATOSUS; VEIN THROMBOSIS; YOUNG ADULT; ADOLESCENT; BLOOD; COMPARATIVE STUDY; IMMUNOLOGY; VERY ELDERLY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIPHOSPHOLIPID SYNDROME; BETA 2-GLYCOPROTEIN I; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 85018266039     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203316671812     Document Type: Article

References (27)

1. Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006; 4: 295-306.
2. Tebo AE,. Antiphospholipid syndrome and the relevance of antibodies to negatively charged phospholipids in diagnostic evaluation. Lupus 2014; 23: 1313-1316.
3. Pierangeli SS, de Groot PG, Dlott J, et al. 'Criteria' aPL tests: Report of a task force and preconference workshop at the 13th International Congress on Antiphospholipid Antibodies, Galveston, Texas, April 2010. Lupus 2011; 20: 182-190.
4. Van Hoecke F, Persijn L, Decavele AS, et al. Performance of two new, automated chemiluminescence assay panels for anticardiolipin and anti-beta2-glycoprotein I antibodies in the laboratory diagnosis of the antiphospholipid syndrome. Int J Lab Hematol 2012; 34: 630-640.
5. Devreese KM, Pierangeli SS, de Laat B, et al. Testing for antiphospholipid antibodies with solid phase assays: Guidance from the SSC of the ISTH. J Thromb Haemost 2014; 12: 792-795.
6. Bertolaccini ML, Amengual O, Andreoli L, et al. 14th International Congress on Antiphospholipid Antibodies Task Force. Report on antiphospholipid syndrome laboratory diagnostics and trends. Autoimmun Rev 2014; 13: 917-930.
7. Harris EN, Pierangeli SS,. A more specific ELISA assay for the detection of antiphospholipid antibodies. Clin Immunol News 1995; 15: 26-28.
8. Budd R, Harley E, Quarshie A, et al. A re-appraisal of the normal cut-off assignment for anticardiolipin IgM tests. J Thromb Haemost 2006; 4: 2210-2214.
9. Suh-Lailam BB, Cromar A, Davis KW, et al. APhL antibody ELISA as an alternative to anticardiolipin test for the diagnosis of antiphospholipid syndrome. Int J Clin Exp Pathol 2012; 5: 210-215.
10. Pierangeli SS, Stewart M, Silva LK, et al. An antiphospholipid wet workshop: 7th International Symposium on Antiphospholipid Antibodies. J Rheumatol 1998; 25: 156-160.
11. Forastiero R, Papalardo E, Watkins M, et al. Evaluation of different immunoassays for the detection of antiphospholipid antibodies: Report of a wet workshop during the 13th International Congress on Antiphospholipid Antibodies. Clin Chim Acta 2014; 428: 99-105.
12. Pierangeli SS, Harris EN,. Advances in antiphospholipid antibody testing. Clin Appl Immunol Rev 2000; 1: 59-72.
13. Day HM, Thiagarajan P, Ahn C, et al. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: Clinical correlations in comparison with other antiphospholipid antibody tests. J Rheumatol 1998; 25: 667-674.
14. Merkel PA, Chang Y, Pierangeli SS, et al. Comparison between the standard anticardiolipin antibody test and a new phospholipid test in patients with connective tissue diseases. J Rheumatol 1999; 26: 591-596.
15. Reveille JD, Moulds JM, Ahn C, et al. Systemic lupus erythematosus in three ethnic groups: I. The effects of HLA class II, C4, and CR1 alleles, socioeconomic factors, and ethnicity at disease onset. LUMINA Study Group. Lupus in minority populations, nature versus nurture. Arthritis Rheum 1998; 41: 1161-1172.
16. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-1277.
17. Pierangeli SS, Harris EN,. A protocol for determination of anticardiolipin antibodies by ELISA. Nat Protoc 2008; 3: 840-848.
18. Solano C, Lamuno M, Vargas A, et al. Comparison of the 1999 Sapporo and 2006 revised criteria for the classification of the antiphospholipid syndrome. Clin Exp Rheumatol 2009; 27: 914-919.
19. Leroy V, Arvieux J, Jacob MC, et al. Prevalence and significance of anticardiolipin, anti-beta2 glycoprotein I and anti-prothrombin antibodies in chronic hepatitis C. Br J Haematol 1998; 101: 468-474.
20. Von Landenberg P, Lehmann HW, Knoll A, et al. Antiphospholipid antibodies in pediatric and adult patients with rheumatic disease are associated with parvovirus B19 infection. Arthritis Rheum 2003; 48: 1939-1947.
21. Santiago M, Martinelli R, Ko A, et al. Anti-beta2 glycoprotein I and anticardiolipin antibodies in leptospirosis, syphilis and Kala-azar. Clin Exp Rheumatol 2001; 19: 425-430.
22. Danowski A, Kickler TS, Petri M,. Anti-beta2-glycoprotein I: prevalence, clinical correlations, and importance of persistent positivity in patients with antiphospholipid syndrome and systemic lupus erythematosus. J Rheumatol 2006; 33: 1775-1779.
23. Lopez LR, Dier KJ, Lopez D, et al. Anti-beta 2-glycoprotein I and antiphosphatidylserine antibodies are predictors of arterial thrombosis in patients with antiphospholipid syndrome. Am J Clin Pathol 2004; 121: 142-149.
24. Bertolaccini ML, Amengual O, Atsumi T, et al. 'Non-criteria' aPL tests: Report of a task force and preconference workshop at the 13th International Congress on Antiphospholipid Antibodies, Galveston, TX, USA, April 2010. Lupus 2011; 20: 191-205.
25. de Jesus GR, Agmon-Levin N, Andrade CA, et al. 14th International Congress on Antiphospholipid Antibodies Task Force report on obstetric antiphospholipid syndrome. Autoimmun Rev 2014; 13: 795-813.
26. Uribe AG, McGwin G Jr., Reveille JD, et al. What have we learned from a 10-year experience with the LUMINA (Lupus in Minorities; Nature vs. nurture) cohort? Where are we heading? Autoimmun Rev 2004; 3: 321-329.
27. Borchers AT, Naguwa SM, Shoenfeld Y, et al. The geoepidemiology of systemic lupus erythematosus. Autoimmun Rev 2010; 9: A277-A287.